Steven Bellon
Chief Tech/Sci/R&D Officer at FOGHORN THERAPEUTICS INC.
Net worth: 1 M $ as of 2024-05-30
Steven Bellon active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2022-01-09 | - |
| Corporate Officer/Principal | 2016-05-31 | 2022-01-09 |
Career history of Steven Bellon
Former positions of Steven Bellon
| Companies | Position | Start | End |
|---|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Director/Board Member | 2008-08-31 | 2016-04-30 |
| Corporate Officer/Principal | 2008-08-31 | 2016-04-30 |
Training of Steven Bellon
| Haverford College | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Steven Bellon
- Experience
